Inari Medical, Inc. NARI recently announced the first patient enrollment in the PEERLESS II study. PEERLESS II, a prospective, global, multi-center randomized controlled trial (RCT), is expected to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback